Conference
Bortezomib is active in Waldenstrom's Macroglobulinemia (WM) - Results of a National Cancer Institute of Canada (NCIC) phase II study in previously untreated or treated WM.
Authors
Chen CI; Kouroukis T; White D; Voralia M; Stadtmauer E; Wright J; Powers J; Eisenhauer E
Volume
24
Pagination
pp. 432S-432S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2006
Name of conference
42nd Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
GA, Atlanta
Conference start date
June 2, 2006
Conference end date
June 6, 2006
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X